You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.
The company presented new evidence for the sensitivity of its multi-cancer early detection test and robustness of its automated library prep system.
The two firms aim to bring down costs and turnaround time with two newly-launched sequencing tests for respiratory pathogens, RVOP 2 and Explify RPIP.
The group noted that while molecular diagnostics are powerful tools, physicians' enthusiasm for such tests can lead to improper and excessive use.
At an AMP virtual meeting workshop, a Mayo Clinic lab director offered advice on what diseases to include, how to handle VUSs, and other considerations for ECS.
In a conversation at the Association for Molecular Pathology meeting, the directors touched on topics such as test allocation and staffing and reagent shortages.
The firm's new application of its BCR-ABL test will be able to detect p190 transcripts and is currently for research use only.
The COVID-19 pandemic is the highest priority for most, but laboratory organizations are also looking ahead with longer-term goals for the new presidency.
Laboratories are continuing to experience supply chain interruptions and are facing significant staffing shortages, the report found.
The organizations have also requested a meeting with the White House Pandemic Task Force to discuss issues surrounding supply allocation for COVID-19 testing.